Last updated: 2026-09-16 09:46:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Coya Therapeutics, Inc. (COYA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4,60, with a market capitalisation of $108,84M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3,71 to $7,75. This page covers its latest market performance, valuation, price trends and company information.
$108,84M | |
$4,72 | |
$10,69 | |
$3,21 | |
$4,65 | |
1,00 | |
183,69K | |
-- | |
$7,75 | |
$3,71 | |
-- | |
-- |
Coya Therapeutics, Inc. (COYA) is trading at $4,60 in pre-market trading as of 2026-09-16 08:07:00, down 1,05% ($0,05) from the previous close of $4,65
Pre-market trading shows how investors are pricing COYA before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Coya Therapeutics, Inc. (COYA) moved from $4,76 to $4,60, representing a decline of 3,34% ($0,16).
The stock traded between $4,33 and $4,82 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 128,77 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 22,1%
COYA is currently trading at $4,60, placing it 22,1% of the way from its 52-week low of $3,71 to its 52-week high of $7,75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 8 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Coya Therapeutics, Inc. (COYA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.